We are pleased to advise that the Office of Drug Control has now approved LeafCann’s Cannabis Manufacturing Licence.
The Narcotic Drugs Amendment in February 2016 means Victoria is the first Australian state to legalise the manufacture and supply of medical cannabis to support people in chronic pain.
LeafCann Medical Cannabis is striving to be the first triple P (People, Planet, Profit) medical cannabis grower in Australia. Our primary focus will be to provide high quality, cannabis products to patients across Australia, growing a loyal base of customers with our fair prices and sustainable commitment to community and charity.
It’s our aim to become industry thought leaders through our partnerships with universities and other medical research organisations.
With headquarters in South Australia, a world-class management team and expert advisory board, our commercial ‘Seed to Sale’ model focuses on Australian-based cultivation, research and development, manufacturing and distribution of medical cannabis.